Summary
The serum level of pepsinogen I (PG I) and pepsinogen II (PG II), and the PG I/PG II ratio were compared with the surface area of the fundic mucosa, as determined endoscopically by the Congo red staining method. Reduction in the area of the fundic mucosa due to gastritis was associated with stepwise reduction in the PG I levels and the PG I/PG II ratios. Reduction in the area of the fundic mucosa was also associated with decreases in the basal acid output, maximal acid output (MAO), the basal pepsin output and the stimulated pepsin output. The best sensitivity and specificity levels for the diagnosis of normal mucosa and severe gastritis were obtained with the PG I/PG II ratio and the MAO. A retrospective study of 58 patients with gastric cancer and 162 cancer-free patients showed that a PG I/PG II ratio identified 86.2% of all carcinomas and 87.5% of early carcinomas. Although this test gave a positive rate of 36% among the cancer-susceptible age group controls, its use would lower the cost of mass screening by targeting a smaller test population.
Similar content being viewed by others
References
Segi M, et al: World cancer mortality. Gann Monogr Cancer Res 1981, 26: 121–274
Correa P, et al: Gastric cancer in Colombia. III. Natural histry of precursor lesions. J Natl Cancer Inst 1976, 57: 1027–1035
Kawachi T, et al: Precancerous changes in the stomach. Cancer Res 1976, 36: 2673–2677
Bock OAA, et al: The serum pepsinogen level with special reference to the histology of the gastric mucosa. Gut 1953, 4: 106–111
Hirschowitz BI: Pepsinogen: its origin, secretion and excretion. Physiol Rev 1957, 37: 475–511
Mirsky IA, et al: Blood plasma pepsinogen. II. The activity of plasma from normal subjects, patients with duodenal ulcer and patients with pernicious anemia. J Lab Clin Med 1952, 40: 188–199
Samloff IM, et al: A study of the relationship between serum group I pepsinogen levels and gastric acid secretion. Gastroenterology 1975, 69: 1196–2000
Varis K, et al: An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci 1979, 24: 187–191
Samloff IM: Pepsinogens I and II: Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982, 82: 26–33
Samloff IM, et al: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982, 83: 204–209
Okuda S, et al: An endoscopic method to investigate the gastric acid secretion in “Proc 1st Congr Int Soc Endoscopy”, Hitachi Printing Co, Tokyo, 1966; 221–226
Tatsuta M, et al: Studies on gastritis in the upper portion of stomach by endoscopic Congo red test. Endoscopy 1973, 5: 61–69
Ichinose M, et al: Radioimmunoassay of Group II pepsinogen in human serum. Clin Chimica Acta 1982, 122: 61–69
Ichinose M, et al: Radioimmunoassay of serum group I and group II pspsinogens in normal controls and in patients with various disorders. Clin Chimica Acta 1982, 126: 183–191
Mild K, et al: Serum pepsinogens in peptic ulcer and gastric cancer, in “Proc Int Workshop Aspartic Proteinases”, Tokyo, 1985; 17
Miki K, et al: Upper gastrointestinal mass survey with panendoscopy in a workplace. Gastrointestinal Endoscopy 1982, 28: 70–72
Anson ML: The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J Gen Physiol 1939, 22: 79–89
Feinstein AR: On the sensitivity, specificity and discrimination of diagnostic tests, in “Clinical biostatistics”, Mosby CV, St Louis, 1977; 214–226
Kimura K: Chronological transition of the fundicpyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972, 63: 584–592
Samloff IM: Immunologic studies of human group I pepsinogens. J Immunol 1971, 106: 962–968
Kubo T, et al: Intestinal metaplasia of gastric mucosa in autopsy materials in Hiroshima and Yamaguchi districts. Gann 1971, 62: 49–53
Stemmermann GN, et al: Intestinal metaplasia of the stomach in Hawaii and Japan. A study of its relation to serum pepsinogen I, gastrin and parietal cell antibodies. Am J Dis 1978, 23: 815–820
Stemmermann GN, et al: Serum pepsinogen I and gastrin in relation to extent and location of intestinal metaplasia in the surgically resected stomach. Dig Dis Sci 1980, 25: 680–687
Nomura AMY, et al: Serum pepsinogen I as a predictor of stomach cancer. Ann Int Med 1980, 93: 537–540
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miki, K., Ichinose, M., Shimizu, A. et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 22, 133–141 (1987). https://doi.org/10.1007/BF02774209
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774209